On the Record · Molecular Data
Molecular Data acquisitions, on the record
The businesses Molecular Data bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Shaanxi MOLBASEWord for word“On October 14, 2018, Shanghai MOLBASE acquired 100% equity interest in Shaanxi MOLBASE.” 20-F for 2019 | acquisition | October 14, 2018 | — |
MOBEI (Tianjin) Biotechnology Co., LtdWord for word“*1 . On July 13, 2020, MKD HK acquired 100 % equity of MOBEI (Tianjin) Biotechnology Co., Ltd from its related party MOBEI (Shanghai) Biotechnology Co., Ltd, the transfer consideration is 0 RMB.” 20-F for 2020 | acquisition | On July 13, 2020 | 0 RMB |
Read from Molecular Data’s annual reports (20-F for 2020, 20-F for 2019) and the financial data it files with the SEC, as of 2021-05-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.